Lipotoxicity-Induced PRMT1 Exacerbates Mesangial Cell Apoptosis via Endoplasmic Reticulum Stress

Min-Jung Park1, Ho Jae Han2,3, Dong-Il Kim4

  • 1Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. minjunp@med.umich.edu.

Insights

High fat diets cause kidney damage by promoting cell death in the glomerulus. Protein arginine methyltransferase 1 (PRMT1) drives this process, suggesting it as a therapeutic target for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Diabetic nephropathy (DN) progression is linked to lipotoxicity and mesangial cell apoptosis.
  • Protein arginine methyltransferases (PRMTs) regulate cellular functions, with PRMT1 elevated in diabetic kidney conditions.
  • The role of PRMTs in mesangial cells during diabetic nephropathy is not well understood.

Purpose of the Study:

  • To investigate the role of PRMTs in lipotoxicity-induced mesangial cell apoptosis.
  • To elucidate the signaling pathways involved in PRMT-mediated mesangial cell apoptosis under lipotoxic conditions.

Main Methods:

  • Mesangial cells were treated with palmitate to induce lipotoxicity and endoplasmic reticulum (ER) stress.
  • PRMT1 expression and activity were assessed following palmitate treatment.
  • PRMT1 knockdown was performed to evaluate its effect on palmitate-induced apoptosis and ER stress.
  • A mouse model of high fat diet-induced kidney damage was used, with PRMT1 haploinsufficient mice.

Main Results:

  • Palmitate treatment induced mesangial cell apoptosis through PERK and ATF6-mediated ER stress.
  • Palmitate increased PRMT1 expression and activity in mesangial cells.
  • Knockdown of PRMT1 attenuated palmitate-induced ER stress and mesangial cell apoptosis.
  • Glomerular apoptosis in mice fed a high-fat diet was reduced in PRMT1 haploinsufficient mice.

Conclusions:

  • Lipotoxicity-induced PRMT1 expression promotes ER stress and mesangial cell apoptosis in diabetic nephropathy.
  • Targeting PRMT1 offers a potential therapeutic strategy for preventing diabetic nephropathy exacerbation.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K